Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.05
Delayed Data
As of Dec 13
 +0.18 / +0.82%
Today’s Change
8.31
Today|||52-Week Range
22.81
+51.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash542.0M1.2B2.0B1.9B
 
 
 
 
 
Short Term Investment Cash-116.9M668.0M803.3M19.6M
 
 
 
 
 
Cash & Short Term Investments543.0M1.2B2.0B1.9B
 
 
 
 
 
 
ReceivablesReceivables2.5B2.1B2.1B2.2B
 
 
 
 
 
 
InventoriesInventories1.1B1.1B1.1B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses8.0M------
 
 
Other Current Assets948.0M915.0M787.0M752.0M
 
 
 
 
 
Current Assets5.1B5.3B6.0B5.9B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.5B------
 
 
Depreciation-1.2B------
 
 
Intangible Assets34.7B33.9B33.4B31.6B
 
 
 
 
 
Other Assets37.0B35.5B34.2B32.5B
 
 
 
 
 
Total Assets43.5B42.3B41.7B40.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable324.0M368.0M371.0M407.0M
 
 
 
 
 
Short Term Debt7.0M353.0M813.0M925.0M
 
 
 
 
 
Accrued Expenses12.0M19.0M12.0M--
 
 
 
 
Other Current Liabilities2.9B3.1B2.9B3.0B
 
 
 
 
 
Other Liabilities3.6B4.2B4.5B4.7B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt29.8B28.2B27.6B26.2B
 
 
 
 
 
Deferred Taxes-5.3B-4.3B-4.1B-2.1B
 
 
 
 
 
Other Liabilities1.0B954.0M859.0M908.0M
 
 
 
 
 
Total Liabilities40.3B38.3B37.7B34.6B
 
 
 
 
 
 
EquityMinority Interest-3.0M-1.0M-1.0M-1.0M
 
 
 
 
 
Preferred Stock0.000.00------
Common Equity3.2B3.9B3.9B5.3B
 
 
 
 
 
Total Shareholder Equity3.2B3.9B3.9B5.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding347.8M347.9M348.5M348.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.